<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0208851.ref049">
 <label>49</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Kam</surname>
   <given-names>YW</given-names>
  </name>, 
  <name>
   <surname>Lum</surname>
   <given-names>FM</given-names>
  </name>, 
  <name>
   <surname>Teo</surname>
   <given-names>TH</given-names>
  </name>, 
  <name>
   <surname>Lee</surname>
   <given-names>WW</given-names>
  </name>, 
  <name>
   <surname>Simarmata</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Harjanto</surname>
   <given-names>S</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein</article-title>. 
  <source>EMBO molecular medicine</source>. 
  <year>2012</year>;
  <volume>4</volume>(
  <issue>4</issue>):
  <fpage>330</fpage>â€“
  <lpage>43</lpage>. 
  <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/emmm.201200213" xmlns:xlink="http://www.w3.org/1999/xlink">10.1002/emmm.201200213</ext-link> ; PubMed Central PMCID: PMC3376860.
  <?supplied-pmid 22389221?>
  <pub-id pub-id-type="pmid">22389221</pub-id>
 </mixed-citation>
</ref>
